14-day Premium Trial Subscription Sign Up For FreeGet Free

bluebird bio Stock Forecast NASDAQ:BLUE

Price Target and Analyst Ratings

Most Recent Rating

On August 10, 2021 "Mizuho" gave "$70.00 - $29.00" rating for BLUE. The price target was set to $19.73+8.6%.

Last 30 Days

Historical Ratings

Date Rating Action Authority Current Price Target Price
2021-08-10 $70.00 - $29.00 Target Lowered by Mizuho $20.04 $19.73+8.6%
2021-08-10 $60.00 - $25.00 Downgraded by Wells Fargo & Company $20.04 $18.16→27.4%
2021-08-10 $70.00 - $29.00 Reiterated by Mizuho $20.04 $18.16→27.4%
2021-08-10 $41.00 - $22.00 Target Lowered by Bank of America $20.04 $19.73+8.6%
2021-08-10 $63.00 - $23.00 Downgraded by The Goldman Sachs Group $20.04 $18.16→27.4%
2021-08-10 $86.00 - $20.00 Downgraded by Canaccord Genuity $20.04 $18.90+4.1%
2021-08-10 $29.00 - $21.00 Target Lowered by BMO Capital Markets $20.04 $19.73+8.6%
2021-08-09 $31.00 - $18.00 Target Lowered by Stifel Nicolaus $18.16 $18.15→27.5%
2021-08-09 Downgraded by SVB Leerink $18.16 $18.78→25.0%
2021-08-01 Reiterated by SVB Leerink $25.41 $25.410.0%
2021-07-16 $36.00 - $35.00 Target Lowered by Morgan Stanley $26.78 $27.46→0.3%
2021-07-01 Buy - Hold Downgraded by Berenberg Bank $32.42 $35.00
2021-06-15 Hold Reiterated by Oppenheimer $32.83
2021-06-10 Buy Initiated by SVB Leerink $33.89
2021-04-26 Equal Weight Target Lowered by Morgan Stanley $29.48 $45.00 → $36.00
2021-04-21 Market Perform Target Lowered by BMO Capital Markets $28.12 $35.00 → $31.00
2021-04-19 Equal Weight Target Lowered by Morgan Stanley $27.98 $45.00 → $36.00
2021-03-29 Buy Reiterated by Jefferies Financial Group $30.94
2021-03-29 Market Perform Target Raised by BMO Capital Markets $30.94 $31.00 → $35.00
2021-03-29 Target Raised by Piper Sandler $30.94 $30.00 → $35.00
2021-03-29 Outperform Target Raised by SVB Leerink $30.94 $69.00 → $72.00
2021-03-28 Hold Reiterated by Oppenheimer $29.98
2021-03-16 Neutral - Buy Upgraded by Mizuho $32.39 $34.00 → $69.00
2021-03-14 Buy Reiterated by SVB Leerink $32.43
2021-03-10 Target Raised by Stifel Nicolaus $32.48 $26.00 → $31.00
2021-03-10 Neutral - Buy Upgraded by Mizuho $32.48 $34.00 → $69.00
2021-03-08 Equal Weight Target Lowered by Morgan Stanley $28.25 $50.00 → $45.00
2021-03-02 Equal Weight Target Lowered by Morgan Stanley $30.80 $50.00 → $45.00
2021-02-24 Equal Weight Target Lowered by Barclays $25.92 $31.00 → $27.00
2021-02-17 Market Perform Target Raised by BMO Capital Markets $28.02 $36.00 → $56.00
2021-02-17 Hold Target Lowered by Stifel Nicolaus $28.02 $48.00 → $35.00
2021-02-17 Overweight - Neutral Downgraded by JPMorgan Chase & Co. $28.02 $76.00 → $39.00
2021-02-17 Outperform - Sector Perform Downgraded by Royal Bank of Canada $28.02
2021-02-16 Outperform - Market Perform Downgraded by Oppenheimer $28.44
2021-02-16 Buy - Neutral Downgraded by Bank of America $28.44
2021-02-16 Outperform - Neutral Downgraded by Wedbush $28.44
2021-02-16 Outperform - Market Perform Downgraded by William Blair $28.44
2021-02-16 Neutral Target Lowered by Piper Sandler $28.44 $55.00 → $35.00
2021-02-16 Buy - Neutral Downgraded by Mizuho $28.44
2020-12-09 Buy - Hold Downgraded by Maxim Group $42.61
2020-12-07 Buy Reiterated by Mizuho $45.40
2020-11-11 Buy Initiated by Berenberg Bank $45.48
2020-11-11 Equal Weight Target Lowered by Morgan Stanley $45.48 $68.00 → $50.00
2020-11-06 Outperform Target Lowered by Wedbush $45.89 $81.00 → $73.00
2020-11-05 Buy - Hold Downgraded by Stifel Nicolaus $48.83 $77.00 → $51.00
2020-11-05 Outperform Target Lowered by Oppenheimer $48.83 $111.00 → $90.00
2020-11-05 Outperform Target Lowered by Royal Bank of Canada $48.83 $100.00 → $93.00
2020-11-05 Buy Target Lowered by Bank of America $48.83 $100.00 → $81.00
2020-11-05 Outperform Target Lowered by SVB Leerink $48.83 $133.00 → $99.00
2020-11-05 Overweight - Equal Weight Downgraded by Barclays $48.83
2020-11-05 Overweight Target Lowered by JPMorgan Chase & Co. $48.83 $140.00 → $76.00
2020-11-05 Overweight Target Lowered by Wells Fargo & Company $48.83 $94.00 → $81.00
2020-11-05 Buy Target Lowered by Canaccord Genuity $48.83 $118.00 → $86.00
2020-11-05 Outperform - Market Perform Downgraded by BMO Capital Markets $48.83 $108.00 → $56.00
2020-11-04 Neutral Target Lowered by Piper Sandler $58.55 $70.00 → $55.00
2020-11-02 Market Perform - Outperform Upgraded by William Blair $53.09
2020-10-19 Buy Initiated by Mizuho $54.55 $123.00
2020-10-19 Buy Initiated by Mizuho $54.55
2020-08-31 Buy Initiated by Oppenheimer $59.30 $111.00
2020-08-30 Hold Reiterated by William Blair $56.75
2020-08-19 Buy Reiterated by JPMorgan Chase & Co. $60.95
2020-08-10 Equal Weight Target Lowered by Morgan Stanley $65.77 $73.00 → $68.00
2020-08-06 Outperform Target Lowered by BMO Capital Markets $63.84 $112.00 → $108.00
2020-08-06 Outperform Target Lowered by Wedbush $63.84 $89.00 → $81.00
2020-07-29 Buy Initiated by Oppenheimer $62.34 $111.00
2020-07-13 Buy Target Lowered by Bank of America $60.71 $104.00 → $100.00
2020-06-12 Outperform Target Raised by SVB Leerink $63.93 $129.00 → $133.00
2020-06-01 Buy Initiated by Oppenheimer $64.38 $111.00
2020-05-28 Outperform Target Raised by SVB Leerink $60.81 $125.00 → $129.00
2020-05-28 Equal Weight Target Raised by Morgan Stanley $60.81 $69.00 → $73.00
2020-05-13 Buy Reiterated by Barclays $55.82
2020-05-12 Outperform Target Raised by BMO Capital Markets $56.86 $107.00 → $112.00
2020-05-12 Outperform Initiated by Royal Bank of Canada $56.86
2020-05-12 Buy Reiterated by Canaccord Genuity $56.86 $118.00
2020-05-11 Neutral Target Lowered by Piper Sandler $60.23 $75.00 → $70.00
2020-04-15 Equal Weight Target Lowered by Morgan Stanley $47.37 $92.00 → $69.00

BLUE Stock Trend

Given the current short-term trend, the stock is expected to fall -51.39% during the next 3 months and, with a 90% probability hold a price between $5.70 and $8.59 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Data

Date Bottom Mid Top
2021-09-20 $11.43 $14.40 $17.38
2021-09-21 $11.13 $14.11 $17.09
2021-09-22 $10.83 $13.81 $16.79
2021-09-23 $10.54 $13.51 $16.49
2021-09-24 $10.24 $13.22 $16.20
2021-09-27 $9.94 $12.92 $15.90
2021-09-28 $9.65 $12.62 $15.60
2021-09-29 $9.35 $12.33 $15.31
2021-09-30 $9.05 $12.03 $15.01
2021-10-01 $8.76 $11.73 $14.71
2021-10-04 $8.46 $11.44 $14.42
2021-10-05 $8.16 $11.14 $14.12
2021-10-06 $7.87 $10.84 $13.82
2021-10-07 $7.57 $10.55 $13.53
2021-10-08 $7.27 $10.25 $13.23
2021-10-11 $6.98 $9.95 $12.93
2021-10-12 $6.68 $9.66 $12.64
2021-10-13 $6.38 $9.36 $12.34
2021-10-14 $6.09 $9.06 $12.04
2021-10-15 $5.79 $8.77 $11.75
2021-10-18 $5.49 $8.47 $11.45
2021-10-19 $5.20 $8.17 $11.15
2021-10-20 $4.90 $7.88 $10.86
2021-10-21 $4.60 $7.58 $10.56
2021-10-22 $4.31 $7.28 $10.26
2021-10-25 $4.01 $6.99 $9.97
2021-10-26 $3.71 $6.69 $9.67
2021-10-27 $3.42 $6.39 $9.37
2021-10-28 $3.12 $6.10 $9.08
2021-10-29 $2.82 $5.80 $8.78

About bluebird bio

bluebird bio bluebird bio, Inc., a clinical-stage biotechnology company, focuses on developing transformative gene therapies for severe genetic and rare diseases. Its product candidates include Lenti-D, which is in phase II/III clinical studies for the treatment of cerebral adrenoleukodystrophy, a rare, hereditary neurological disorder; and LentiGlobin that is in phase I/II clinical studies for the treatment of beta-thalassemia major and severe sickle cell di... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 95.000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT